Cas no 1185306-82-4 (3,5-(Dimethyl-d6)-4-(methoxy-d3)-bromobenzene)
3,5-(Dimethyl-d6)-4-(methoxy-d3)-bromobenzene Chemical and Physical Properties
Names and Identifiers
-
- 3,5-(Dimethyl-d6)-4-(methoxy-d3)-bromobenzene
- SY022626
- 4-bromo-2,6-dimethyl-anisole
- 2,6-dimethyl-4-bromo-methoxybenzene
- 4-bro-mo-2,6-dimethyl anisole
- 4-Bromo-2,6-dimethylanisole
- B3016
- BP-20267
- DB-042914
- 5-Bromo-2-methoxy-1,3-dimethylbenzene
- MFCD00143259
- EN300-21230
- J-514619
- 1185306-82-4
- AKOS000121359
- PS-7944
- 3,5-dimethyl-4-methoxybromobenzene
- NSC128395
- SCHEMBL363341
- NSC-128395
- 2,6-dimethyl-4-bromoanisole
- 4-Bromo-2,6-dimethylanisole, 97%
- DTXSID50299144
- 1-bromo-3,5-dimethyl-4-methoxybenzene
- CS-W014901
- 5-Bromo-2-methoxy-m-xylene
- J-800233
- 4-BROMO-2,6-DIMETHYL-METHOXYBENZENE
- Benzene, 5-bromo-2-methoxy-1,3-dimethyl-
- J-640232
- 14804-38-7
- Z104494704
-
- Inchi: 1S/C9H11BrO/c1-6-4-8(10)5-7(2)9(6)11-3/h4-5H,1-3H3/i1D3,2D3,3D3
- InChI Key: MMARFGDTMJBIBK-GQALSZNTSA-N
- SMILES: O(C1C(=CC(Br)=CC=1C([2H])([2H])[2H])C([2H])([2H])[2H])C([2H])([2H])[2H]
Computed Properties
- Exact Mass: 213.99933g/mol
- Monoisotopic Mass: 213.99933g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 1
- Heavy Atom Count: 11
- Rotatable Bond Count: 1
- Complexity: 115
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 3.3
- Topological Polar Surface Area: 9.2?2
3,5-(Dimethyl-d6)-4-(methoxy-d3)-bromobenzene Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd. | D890117-5mg |
3,5-(Dimethyl-d6)-4-(methoxy-d3)-bromobenzene |
1185306-82-4 | 95% | 5mg |
¥1,860.00 | 2022-01-12 | |
| SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd. | D890117-25mg |
3,5-(Dimethyl-d6)-4-(methoxy-d3)-bromobenzene |
1185306-82-4 | 95% | 25mg |
¥6,180.00 | 2022-01-12 |
3,5-(Dimethyl-d6)-4-(methoxy-d3)-bromobenzene Related Literature
-
Alvin Tanudjaja,Shinsuke Inagi,Fusao Kitamura,Toshikazu Takata,Ikuyoshi Tomita Dalton Trans., 2021,50, 3037-3043
-
Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383
-
Luke L. Lairson,Warren W. Wakarchuk Chem. Commun., 2007, 365-367
-
Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
-
Bo Cao,Yin Wei Chem. Commun., 2018,54, 2870-2873
Additional information on 3,5-(Dimethyl-d6)-4-(methoxy-d3)-bromobenzene
Comprehensive Introduction to 3,5-(Dimethyl-d6)-4-(methoxy-d3)-bromobenzene (CAS No. 1185306-82-4)
3,5-(Dimethyl-d6)-4-(methoxy-d3)-bromobenzene (CAS No. 1185306-82-4) is a deuterated aromatic compound widely utilized in pharmaceutical research, agrochemical development, and material science. Its unique isotopic labeling (Dimethyl-d6 and methoxy-d3) enhances metabolic stability and traceability in deuterated drug discovery, making it a critical intermediate for isotope-labeled synthesis. The presence of a bromine substituent further enables cross-coupling reactions, aligning with the growing demand for Pd-catalyzed transformations in modern organic chemistry.
The compound’s structural features, including the deuterated methyl groups and bromo-aromatic core, cater to applications in NMR spectroscopy and mass spectrometry. Researchers leverage its isotopic purity (>98%) to study reaction mechanisms or quantify metabolites, addressing trending topics like precision medicine and sustainable chemistry. As the pharmaceutical industry shifts toward deuterium-enhanced drugs (e.g., Deutetrabenazine), 1185306-82-4 gains prominence as a scaffold for next-generation therapeutics.
From a synthetic perspective, 3,5-(Dimethyl-d6)-4-(methoxy-d3)-bromobenzene serves as a versatile building block for C-H functionalization and heterocycle formation. Its compatibility with Suzuki-Miyaura and Buchwald-Hartwig couplings aligns with industry efforts to streamline green synthesis protocols. Recent publications highlight its role in designing fluorescent probes and OLED materials, reflecting interdisciplinary interest in optoelectronic applications.
Quality control of CAS 1185306-82-4 adheres to stringent GMP/ISO standards, ensuring reproducibility for high-throughput screening. Analytical data (e.g., HPLC, GC-MS) confirm its suitability for labeled compound libraries, a key resource for AI-driven drug design. Notably, its stability under ambient conditions simplifies storage, addressing logistical challenges in global supply chains.
Environmental and regulatory considerations further underscore its relevance. Unlike non-deuterated analogs, deuterated compounds often exhibit reduced toxicity profiles, aligning with REACH and FDA guidelines. This positions 1185306-82-4 as a sustainable alternative in catalysis and material engineering, topics frequently searched in academic databases and patent filings.
In summary, 3,5-(Dimethyl-d6)-4-(methoxy-d3)-bromobenzene bridges cutting-edge research and industrial applications. Its integration into deuterium chemistry and smart materials exemplifies innovation at the nexus of molecular design and technology convergence.
1185306-82-4 (3,5-(Dimethyl-d6)-4-(methoxy-d3)-bromobenzene) Related Products
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)